Cloverleaf Bio, Inc.
New Haven, CT ยท Biotechnology
Cloverleaf Bio, Inc. is a biotechnology company based in New Haven, Connecticut. In a Form D filed with the SEC on September 9, 2026, it reported raising $14,799,988 from 12 investors as part of an offering of up to $29,599,977. The first sale in the offering took place on August 24, 2026.
- Amount raised
- $14,799,988
- Offering size
- $29,599,977
- Investors so far
- 12
- First sale
- August 24, 2026
- Securities offered
- Equity
- Exemption claimed
- Rule 506(b)
- Industry
- Biotechnology
- Headquarters
- New Haven, Connecticut
- Incorporated
- Delaware, 2023
- Entity type
- Corporation
Filings
| Filed | Form | Raised | Offering size | Investors | Source |
|---|---|---|---|---|---|
| D (new notice) | $14,799,988 | $29,599,977 | 12 | SEC filing |
Figures come from the company's own filing with the SEC and are shown as reported. How to read a Form D.
Other health care raises in Connecticut
| Company | Location | Sector | Raised | Target | Filed |
|---|---|---|---|---|---|
| Thetis Pharmaceuticals LLC | Deep River, CT | Health Care | $560K | $1M | |
| Pantera, Inc. | Hartford, CT | Health Care | $1.4M | $3.5M | |
| Inventure, LLC | Southbury, CT | Health Care | $82K | $82K | |
| Oxbridge Health, Inc. | Norwalk, CT | Health Care | $38.5M | $45M | |
| Convexity Scientific Inc. | New Haven, CT | Health Care | $10M | $13M |